{"title": "Eritrosedimentaci\u00f3n: r\u00e9quiem para una prueba", "author": "Germ\u00e1n Campuzano Maya", "url": null, "hostname": null, "description": "Erythrocyte sedimentation rate is one of the most requested tests to the clinical laboratory. However, its clinical application in the numerous clinical situations where it has been indicated in over 100 years, has been slowly decreasing as new assays, such as those for the acute phase reactants, are being developed, in particular for C-reactive protein, for the diagnosis and treatment of infectious and inflammatory diseases, including rheumatologic and cardiovascular diseases, and tumor markers in malignant diseases. Erythrocyte sedimentation rate has a very low specificity, and is usually performed manually which poses a high hazard to laboratory workers associated with the manipulation of the glass pipettes. After an exhaustive review of the literature in PubMed and Scielo search engines, this module presents the associated conditions in which erythrocyte sedimentation rate has been indicated as a useful assay and the different tests options with higher analytical performance and better cost-effectiveness to replace it. A call is made to the medical community to consider other options with a much higher sensitivity, specificity, and positive and negative predictive values than the erythrocyte sedimentation rate, in each specific clinical situation.", "sitename": "Medicina y Laboratorio", "date": "2010-01-01", "id": null, "license": "CC BY-NC-ND 4.0", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Eritrosedimentaci\u00f3n: r\u00e9quiem para una prueba\nResumen\nLa eritrosedimentaci\u00f3n es una de las pruebas m\u00e1s solicitadas al laboratorio cl\u00ednico. Sin embargo, la utilidad cl\u00ednica de la prueba en la amplia gama de situaciones cl\u00ednicas en donde se la ha indicado en el curso de m\u00e1s de 100 a\u00f1os, paulatinamente ha perdido vigencia frente a la medici\u00f3n de otros analitos como los reactantes de fase aguda, en particular la prote\u00edna C reactiva, para el diagn\u00f3stico y manejo de las enfermedades infecciosas e inflamatorias, incluidas las de origen reumatol\u00f3gico y las enfermedades cardiovasculares, y los marcadores tumorales en las enfermedades malignas. La eritrosedimentaci\u00f3n, adem\u00e1s de ser altamente inespec\u00edfica, depende de m\u00e9todos manuales e implica alto riesgo profesional por los accidentes relacionados con las pipetas de vidrio que se utilizan para hacer la prueba. En este m\u00f3dulo se presenta, tras una exhaustiva revisi\u00f3n bibliogr\u00e1fica de PubMed y Scielo, las indicaciones en donde la prueba fue de utilidad y las alternativas para reemplazarla por pruebas de mejor desempe\u00f1o anal\u00edtico y mejor relaci\u00f3n costo-eficiencia. Se hace un llamado a la comunidad m\u00e9dica para que antes de solicitarla al laboratorio cl\u00ednico consideren otras opciones de mayor sensibilidad, especificidad, valor predictivo positivo y valor predictivo negativo que la eritrosedimentaci\u00f3n, en cada una de las situaciones cl\u00ednicas que la requiera.\nDescargas\nReferencias bibliogr\u00e1ficas\nHernandez JS. Cost-effectiveness of laboratory testing. Arch Pathol Lab Med 2003; 127: 440- 445.\n[https://doi.org/10.5858/2003-127-0440-COLT](https://doi.org/10.5858/2003-127-0440-COLT)\nCampuzano-Maya G. Papel del laboratorio cl\u00ednico en la pr\u00e1ctica m\u00e9dica. Laboratorio al D\u00eda 1995; 5: 22-27.\nHern\u00e1ndez JS, Dale JC, Bennet KE, Varkey P. Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation. Am J Clin Pathol 2010; 133: 8-13.\n[https://doi.org/10.1309/AJCPSB4AL5EHAWTC](https://doi.org/10.1309/AJCPSB4AL5EHAWTC)\nSaadeh C. The erythrocyte sedimentation rate: old and new clinical applications. South Med J 1998; 91: 220-225.\n[https://doi.org/10.1097/00007611-199803000-00001](https://doi.org/10.1097/00007611-199803000-00001)\nBrigden M. The erythrocyte sedimentation rate. Still a helpful test when used judiciously. Post- grad Med 1998; 103: 257-262, 272-254.\n[https://doi.org/10.3810/pgm.1998.05.493](https://doi.org/10.3810/pgm.1998.05.493)\nSox HC, Jr., Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med 1986; 104: 515-523.\n[https://doi.org/10.7326/0003-4819-104-4-515](https://doi.org/10.7326/0003-4819-104-4-515)\nGronlie M, Hjortdahl P. The erythrocyte sedimentation rate; its use and usefulness in primary 24 Medicina & Laboratorio, Volumen 16, N\u00fameros 1-2, 2010 health care. Scand J Prim Health Care 1991; 9: 97-102.\n[https://doi.org/10.3109/02813439109026591](https://doi.org/10.3109/02813439109026591)\nZlonis M. The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use. Clin Lab Med 1993; 13: 787-800.\n[https://doi.org/10.1016/S0272-2712(18)30408-6](https://doi.org/10.1016/S0272-2712(18)30408-6)\nBiernacki E. Ueber die beziehung des plasmas zu den rothen blutkorperchen und uber den werth verschiedener methoden der blutkorperchenvolumbestimmung. Zeitschrift fur Physiologische Chemie 1894; 19: 179-224.\nBiernacki E. Weitere beobachtungen ubre die spontane blutsedimentirung. Zeitschrift fur Physiologische Chemie 1897: 368-398.\n[https://doi.org/10.1515/bchm2.1897.23.4-5.368](https://doi.org/10.1515/bchm2.1897.23.4-5.368)\nFahraeus R. Om hamagglutinationen sarskilt med hansyn till havandeskapet och mojligheten av att diagnostikt utnyttja densamma. Hygiea 1918; 80: 369-382.\nFahraeus R. Uber die Ursachen der verminderten Suspensionsstabiliat der Blutkor-perchen wahrend der Schwangerschaft. Biochem Zeits- chr 1918; 89: 355-364.\nFahraeus R. The suspension-stability of the blood. Acta Medica Scandinavica 1921; 55.\nWestergren A. Studies of the suspension stability of the blood in pulmonary tuberculosis. Acta Med Scand 1921; 54: 282.\n[https://doi.org/10.1111/j.0954-6820.1921.tb15179.x](https://doi.org/10.1111/j.0954-6820.1921.tb15179.x)\nWestergren A. Die senkugsreaktion. Ergeb Inn Med Kinderheilkd 1924; 26: 577-732.\nWestergren A. The technique of the red cell sedimentation reaction. Am Rev Tuberc 1926; 14: 94-101.\nWintrobe MM. Macroscopic examination of the blood: Discussion of its value and description of the use of a single instrument for the determination of sedimentation rate, volume of packed cells, leukocytes and platelets, and of icterus indez. Am J Med Sci 1933; 185: 58-71.\n[https://doi.org/10.1097/00000441-193301000-00007](https://doi.org/10.1097/00000441-193301000-00007)\nRecommendation of measurement of erythrocyte sedimentation rate of human blood. Am J Clin Pathol 1977; 68: 505-507.\n[https://doi.org/10.1093/ajcp/68.4.505](https://doi.org/10.1093/ajcp/68.4.505)\nGuidelines on selection of laboratory tests for monitoring the acute phase response. International Committee for Standardization in Haematology (expert panel on blood rheology). J Clin Pathol 1988; 41: 1203-1212.\n[https://doi.org/10.1136/jcp.41.11.1203](https://doi.org/10.1136/jcp.41.11.1203)\nNCCLS. Reference and selected procedure for erythrocyte sedimentation rate (ERS) test: Approved standard, fourth edition. NCCLS document H2-4A (ISBN 1-56238-424-4). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA 2000\nPribush A, Meyerstein D, Meyerstein N. The mechanism of erythrocyte sedimentation. Part 1: Channeling in sedimenting blood. Colloids Surf B Biointerfaces 2010; 75: 214-223.\n[https://doi.org/10.1016/j.colsurfb.2009.08.036](https://doi.org/10.1016/j.colsurfb.2009.08.036)\nPribush A, Meyerstein D, Meyerstein N. The mechanism of erythrocyte sedimentation. Part 2: The global collapse of settling erythrocyte network. Colloids Surf B Biointerfaces 2010; 75: 224-229.\n[https://doi.org/10.1016/j.colsurfb.2009.08.037](https://doi.org/10.1016/j.colsurfb.2009.08.037)\nThomas RD, Westengard JC, Hay KL, Bull BS. Calibration and validation for erythrocyte sedimentation tests. Role of the International Committee on Standardization in Hematology reference procedure. Arch Pathol Lab Med 1993; 117: 719-723.\nLawrence C, Fabry ME. Erythrocyte sedimentation rate during steady state and painful crisis in sickle cell anemia. Am J Med 1986; 81: 801-808.\n[https://doi.org/10.1016/0002-9343(86)90349-9](https://doi.org/10.1016/0002-9343(86)90349-9)\nSany J. A review of the effects of levamisole on erythrocyte sedimentation rate, acute phase proteins, and anemia. J Rheumatol Suppl 1978; 4: 43-47.\nChien S. Electrochemical interactions between erythrocyte surfaces. Thromb Res 1976; 8: 189- 202.\n[https://doi.org/10.1016/0049-3848(76)90062-1](https://doi.org/10.1016/0049-3848(76)90062-1)\nPittz EP, Jones R, Goldberg L, Coulston F. Interaction of sulfated polysaccharides with plasma membranes--II. Effect of ionic strength, temperature and trypsin digestion of the erythrocyte surface on the aggregation of erythrocytes by iota carrageenans. Biorheology 1977; 14: 33-42.\n[https://doi.org/10.3233/BIR-1977-14104](https://doi.org/10.3233/BIR-1977-14104)\nMarsh NA. The accelerating effect of fibrinogen and early fibrinogen degradation products on erythrocyte sedimentation. Thromb Haemost 1979; 42: 757-763.\n[https://doi.org/10.1055/s-0038-1666914](https://doi.org/10.1055/s-0038-1666914)\nScherer R, Ruhenstroth-Bauer G. Der Mechanismus der Blutkorperchensenkung. XVII. Uber den Zusammenhang und die diagnostische Bedeutung der Lecithin-Cholesterin-Acyltrans- ferase-Aktivitat im Humanserum und DER War- meinaktivierung der Blutkorperchensenkung [Mechanism of blood sedimentation. XVII. Relationship and diagnostic importance of lecithin- cholesterol-acyltransferase (LCAT) activity in human serum and heat-induced inhibition of erythrocyte sedimentation (author's transl)]. Klin Wochenschr 1974; 52: 208-215.\n[https://doi.org/10.1007/BF01468593](https://doi.org/10.1007/BF01468593)\nGambino SR, Dire JJ, Monteleone M, Budd DC. The Westergren Sedimentation Rate, Using K3edta. Tech Bull Regist Med Technol 1965; 35: 1-8.\n[https://doi.org/10.1093/ajcp/43.2_ts.173](https://doi.org/10.1093/ajcp/43.2_ts.173)\nBull BS, Brecher G. An evaluation of the relative merits of the Wintrobe and Westergren sedimentation methods, including hematocrit correction. Am J Clin Pathol 1974; 62: 502-510.\n[https://doi.org/10.1093/ajcp/62.4.502](https://doi.org/10.1093/ajcp/62.4.502)\nWintrobe MM, Landbarg JW. A standardized technique for the blood sedimentation test. Am J Med Sci 1935; 189: 102-115.\n[https://doi.org/10.1097/00000441-193501000-00012](https://doi.org/10.1097/00000441-193501000-00012)\nLloyd HE. Estimation of the erythrocyte sedimentation rate of capillary blood; description of a new method. Ann Rheum Dis 1958; 17: 234-239.\n[https://doi.org/10.1136/ard.17.2.234](https://doi.org/10.1136/ard.17.2.234)\nEvans HE, Glass L, Mercado C. The micro- erythrocyte sedimentation rate in newborn infants. J Pediatr 1970; 76: 448-451.\n[https://doi.org/10.1016/S0022-3476(70)80487-5](https://doi.org/10.1016/S0022-3476(70)80487-5)\nSembiring R, Raid N, Siregar H. The micro erythrocyte sedimentation rate (ESR) in newborn babies. Paediatr Indones 1977; 17: 378-384.\nPawlotsky Y, Chales G, Grosbois B, Louboutin YB, Lenoir P, Bourel M. Sigma SR, a new method of measuring erythrocyte sedimentation rate. Its value in studying the action and interactions of non-steroidal anti-inflammatory agents. Curr Med Res Opin 1978; 5: 412-417.\n[https://doi.org/10.1185/03007997809111907](https://doi.org/10.1185/03007997809111907)\nCha K, Brown EF, Wilmore DW. A new bioelectrical impedance method for measurement of the erythrocyte sedimentation rate. Physiol Meas 1994; 15: 499-508.\n[https://doi.org/10.1088/0967-3334/15/4/011](https://doi.org/10.1088/0967-3334/15/4/011)\nMorris MW, Skrodzki Z, Nelson DA. Zeta sedimentation ratio (ZSR), a replacement for the erythrocyte sedimentation rate (ESR). Am J Clin Pathol 1975; 64: 254-256.\n[https://doi.org/10.1093/ajcp/64.2.254](https://doi.org/10.1093/ajcp/64.2.254)\nSaleem A, Jafari E, Yapit MK. Comparison of zeta sedimentation ratio with Westergren sedimentation rate. Ann Clin Lab Sci 1977; 7: 357- 360.\nTalkers R. Erythrocyte sedimentation rate/zeta sedimentation rate. Emerg Med Clin North Am 1986; 4: 87-93.\n[https://doi.org/10.1016/S0733-8627(20)30984-6](https://doi.org/10.1016/S0733-8627(20)30984-6)\nCaswell M, Stuart J. Assessment of Diesse Vesmatic automated system for measuring erythrocyte sedimentation rate. J Clin Pathol 1991; 44: 946-949.\n[https://doi.org/10.1136/jcp.44.11.946](https://doi.org/10.1136/jcp.44.11.946)\nPlebani M, De Toni S, Sanzari MC, Bernardi D, Stockreiter E. The TEST 1 automated system: a new method for measuring the erythrocyte sedimentation rate. Am J Clin Pathol 1998; 110: 334-340.\n[https://doi.org/10.1093/ajcp/110.3.334](https://doi.org/10.1093/ajcp/110.3.334)\nHappe MR, Battafarano DF, Dooley DP, Rennie TA, Murphy FT, Casey TJ, et al. Validation of the Diesse Mini-Ves erythrocyte sedimentation rate (ESR) analyzer using the Westergren ESR method in patients with systemic inflammatory conditions. Am J Clin Pathol 2002; 118: 14-17.\n[https://doi.org/10.1309/YHYL-8XTH-5JM2-43EJ](https://doi.org/10.1309/YHYL-8XTH-5JM2-43EJ)\nPatton WN, Meyer PJ, Stuart J. Evaluation of sealed vacuum extraction method (Seditainer) for measurement of erythrocyte sedimentation rate. J Clin Pathol 1989; 42: 313-317.\n[https://doi.org/10.1136/jcp.42.3.313](https://doi.org/10.1136/jcp.42.3.313)\nBrowning AC, Burbidge AA, Hodgkins PR. Comparison of the erythrocyte sedimentation rate measured in the eye casualty department by the Seditainer method with an automated system. Eye (Lond) 1999; 13 ( Pt 6): 754-757.\n[https://doi.org/10.1038/eye.1999.222](https://doi.org/10.1038/eye.1999.222)\nCaswell M, Stuart J. Evaluation of a 200 mm long vacuum aspiration tube for measurement of erythrocyte sedimentation rate. J Clin Pathol 1991; 44: 429-430.\n[https://doi.org/10.1136/jcp.44.5.429](https://doi.org/10.1136/jcp.44.5.429)\nBottiger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J 1967; 2: 85-87.\n[https://doi.org/10.1136/bmj.2.5544.85](https://doi.org/10.1136/bmj.2.5544.85)\nShearn MA, Kang IY. Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol 1986; 13: 297-298.\nMiller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) 1983; 286: 266.\n[https://doi.org/10.1136/bmj.286.6361.266](https://doi.org/10.1136/bmj.286.6361.266)\nTaylor AG, Roberts JM. The erythrocyte sedi- mentation rate in normal pregnancy and puerperium; preliminary report and evaluation. J Am Med Womens Assoc 1950; 5: 358-360.\nHamilton GM. The erythrocyte sedimentation rate in pregnancy. J Obstet Gynaecol Br Emp 1953; 60: 409-415.\n[https://doi.org/10.1111/j.1471-0528.1953.tb14079.x](https://doi.org/10.1111/j.1471-0528.1953.tb14079.x)\nTsukamoto S. Studies on the mechanism of the erythrocyte sedimentation rate in pregnancy, delivery and puerperium. J Jpn Obstet Gynecol Soc 1955; 1: 110-112.\nMalmnas C. The erythrocyte sedimentation rate during pregnancy and the puerperium. Acta Med Scand 1958; 161: 323-339.\n[https://doi.org/10.1111/j.0954-6820.1958.tb15548.x](https://doi.org/10.1111/j.0954-6820.1958.tb15548.x)\nBiagioni S, Stella F, Brancatelli D, Palma V, Troccoli R. Erythrocyte sedimentation rate and plasma lipids during pregnancy. Quad Sclavo Diagn 1981; 17: 230-237.\nBrosnan EA, Eales MM. The erythrocyte sedi- mentation rate in pregnancy. N Z Med J 1990; 103: 278.\nvan den Broe NR, Letsky EA. Pregnancy and the erythrocyte sedimentation rate. BJOG 2001; 108: 1164-1167.\n[https://doi.org/10.1016/S0306-5456(01)00267-4](https://doi.org/10.1016/S0306-5456(01)00267-4)\nBurton JL. Effect of oral contraceptives on erythrocyte sedimentation rate in healthy young women. Br Med J 1967; 3: 214-215.\n[https://doi.org/10.1136/bmj.3.5559.214](https://doi.org/10.1136/bmj.3.5559.214)\nCosgriff SW. The Effect of Heparin and Dicumarol Anticoagulant Therapy Upon the Erythrocyte Sedimentation Rate. J Clin Invest 1948; 27: 435-438.\n[https://doi.org/10.1172/JCI101987](https://doi.org/10.1172/JCI101987)\nPalmer JL, Gundersen SM. The effect of dicumarol on the erythrocyte sedimentation rate in normal men. N Engl J Med 1948; 239: 818.\n[https://doi.org/10.1056/NEJM194811252392203](https://doi.org/10.1056/NEJM194811252392203)\nLitwins J, Vesell H, et al. Effect of dicumarol on the erythrocyte sedimentation rate. J Am Med Assoc 1949; 141: 330.\n[https://doi.org/10.1001/jama.1949.62910050005008](https://doi.org/10.1001/jama.1949.62910050005008)\nDenson KW. The effect of sequestrene and heparin on the erythrocyte sedimentation rate. J Clin Pathol 1959; 12: 262-264.\n[https://doi.org/10.1136/jcp.12.3.262](https://doi.org/10.1136/jcp.12.3.262)\nKenawy M, Habib SA, Abu-Khatwa H. Effect of heparin on the erythrocyte sedimentation rate. J Egypt Med Assoc 1960; 43: 431-440.\nGallagher EJ, Gennis P, Brooks F. Clinical use of the erythrocyte sedimentation rate in the evaluation of febrile intravenous drug users. Ann Emerg Med 1993; 22: 776-780.\n[https://doi.org/10.1016/S0196-0644(05)80790-5](https://doi.org/10.1016/S0196-0644(05)80790-5)\nHiga GM, AlKhouri N, Auber ML. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of litera- ture. Pharmacotherapy 1997; 17: 1315-1321.\nPincherle G, Shanks J. Value of the erythrocyte sedimentation rate as a screening test. Br J Prev Soc Med 1967; 21: 133-136.\n[https://doi.org/10.1136/jech.21.3.133](https://doi.org/10.1136/jech.21.3.133)\nAdler SM, Denton RL. The erythrocyte sedimentation rate in the newborn period. J Pediatr 1975; 86: 942-948.\n[https://doi.org/10.1016/S0022-3476(75)80233-2](https://doi.org/10.1016/S0022-3476(75)80233-2)\nBradlow BA, Haggan JM. A comparison of the plasma viscosity and the erythrocyte sedimentation rate as screening tests. S Afr Med J 1979; 55: 415-420.\nKidd HM, Rae MV. Blood sedimentation rates in cancer. Treat Serv Bull 1950; 5: 233-239.\nPeyman MA. The effect of malignant disease on the erythrocyte sedimentation rate. Br J Cancer 1962; 16: 56-71.\n[https://doi.org/10.1038/bjc.1962.6](https://doi.org/10.1038/bjc.1962.6)\nMead J, Larson DL. The erythrocyte sedimentation rate and other blood tests in terminal can- cer. J Am Geriatr Soc 1970; 18: 489-490.\n[https://doi.org/10.1111/j.1532-5415.1970.tb01334.x](https://doi.org/10.1111/j.1532-5415.1970.tb01334.x)\nM\u00f6nig H, Marquardt D, Arendt T, Kloehn S. Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy. Fam Pract 2002; 19: 436-438.\n[https://doi.org/10.1093/fampra/19.5.436](https://doi.org/10.1093/fampra/19.5.436)\nNielsen SE, Andersen B, Baden H. Value of routine estimation of erythrocyte sedimentation rate in surgical patients. Acta Chir Scand 1976; 142: 97-98.\nJuniper RP. The place of the erythrocyte sedimentation rate (ESR) in oral surgery. Br J Oral Surg 1971; 8: 183-191.\n[https://doi.org/10.1016/S0007-117X(70)80078-6](https://doi.org/10.1016/S0007-117X(70)80078-6)\nSchulak DJ, Rayhack JM, Lippert FG, 3rd, Con- very FR. The erythrocyte sedimentation rate in orthopaedic patients. Clin Orthop Relat Res 1982: 197-202.\n[https://doi.org/10.1097/00003086-198207000-00030](https://doi.org/10.1097/00003086-198207000-00030)\nCovey DC, Albright JA. Clinical significance of the erythrocyte sedimentation rate in orthopaedic surgery. J Bone Joint Surg Am 1987; 69: 148- 151.\n[https://doi.org/10.2106/00004623-198769010-00025](https://doi.org/10.2106/00004623-198769010-00025)\nPaakkonen M, Kallio MJ, Kallio PE, Peltola H. Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections. Clin Orthop Relat Res 2009.\n[https://doi.org/10.1007/s11999-009-0936-1](https://doi.org/10.1007/s11999-009-0936-1)\nOkafor B, MacLellan G. Postoperative changes of erythrocyte sedimentation rate, plasma viscosity and C-reactive protein levels after hip surgery. Acta Orthop Belg 1998; 64: 52-56.\nRichter KJ. Clinical significance of the erythrocyte sedimentation rate in orthopaedic surgery. J Bone Joint Surg Am 1987; 69: 794.\n[https://doi.org/10.2106/00004623-198769050-00032](https://doi.org/10.2106/00004623-198769050-00032)\nWestergren A. On the clinical import of the red cell sedimentation reaction in diseases of the jo- ints. Acta Med Scandinav 1926; Supp. 16: 343.\n[https://doi.org/10.1111/j.0954-6820.1926.tb14045.x](https://doi.org/10.1111/j.0954-6820.1926.tb14045.x)\nRafnsson V, Bengtsson C, Lurie M. Erythrocyte sedimentation rate in women with different manifestations of joint disease. Scand J Rheumatol 1982; 11: 87-95.\n[https://doi.org/10.3109/03009748209098168](https://doi.org/10.3109/03009748209098168)\nAdelizzi RA, Zarro VJ. Marked elevation of erythrocyte sedimentation rate in rheumatic disease. J Am Osteopath Assoc 1980; 79: 580- 585.\nAvouac J, Gossec L, Dougados M. Diagnostic and predictive value of anticyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006; 65: 845-851.\n[https://doi.org/10.1136/ard.2006.051391](https://doi.org/10.1136/ard.2006.051391)\nPruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 2010; 12: 203.\n[https://doi.org/10.1186/ar2903](https://doi.org/10.1186/ar2903)\nSimon MA, Schaaf HW, Metz CE. Clinical utility of the erythrocyte sedimentation rate in preoperative evaluation of solitary skeletal lesions. J Orthop Res 1984; 2: 262-268.\n[https://doi.org/10.1002/jor.1100020307](https://doi.org/10.1002/jor.1100020307)\nHass WK, Harter DH. Erythrocyte sedimentation rate in patients with intracranial mass lesions. Neurology 1957; 7: 480-482.\n[https://doi.org/10.1212/WNL.7.7.480](https://doi.org/10.1212/WNL.7.7.480)\nMargerison AC, Mann JR. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and non- malignant lymphadenopathy. Cancer 1985; 55: 1501-1506.\n[https://doi.org/10.1002/1097-0142(19850401)55:7](https://doi.org/10.1002/1097-0142(19850401)55:7)<1501::AID-CNCR2820550714>3.0.CO;2-K\nSickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975; 135: 715-719.\n[https://doi.org/10.1001/archinte.1975.00330050089015](https://doi.org/10.1001/archinte.1975.00330050089015)\nEngervall P, Kallner A, Bjorkholm M. Use of a novel measuring technique for the erythrocyte sedimentation rate--a pilot study in patients with neutropenia and fever. Ups J Med Sci 1994; 99: 187-195.\n[https://doi.org/10.3109/03009739409179363](https://doi.org/10.3109/03009739409179363)\nKohen I, Afzal N, Hussain S, Manu P. Increases in C-reactive protein may predict recurrence of clozapine-induced fever. Ann Pharmacother 2009; 43: 143-146.\n[https://doi.org/10.1345/aph.1L467](https://doi.org/10.1345/aph.1L467)\nAli NS, Hussain SF, Azam SI. Is there a value of mantoux test and erythrocyte sedimentation rate in pre-employment screening of health care workers for tuberculosis in a high prevalence country? Int J Tuberc Lung Dis 2002; 6: 1012- 1016.\nPerry M. Erythrocyte sedimentation rate and C reactive protein in the assessment of suspected bone infection--are they reliable indices? J R Coll Surg Edinb 1996; 41: 116-118.\n[https://doi.org/10.1007/s002780050026](https://doi.org/10.1007/s002780050026)\nBenson L, Goddard J. Comparison of plasma viscosity and erythrocyte sedimentation rates in pulmonary tuberculosis. Am Rev Tuberc 1954; 69: 595-598.\nMatsuoka M. Studies on immunity in tuberculosis; the relation of plasmaglobulin and red cell sedimentation rate to bacteriostasis of tubercle bacilli. Kekkaku 1954; 29: 42-46.\nHouston J, Lawrence JS. The blood sedimentation rate and fractional plasma viscosity in pulmonary tuberculosis. Br J Tuberc Dis Chest 1955; 49: 119-128.\n[https://doi.org/10.1016/S0366-0869(55)80090-1](https://doi.org/10.1016/S0366-0869(55)80090-1)\nBhatia AL, Ghai SN, Dudani AT. Relationship between serum glycoprotein (hexose) and blood sedimentation rate in pulmonary tuberculosis patients. Indian J Med Res 1957; 45: 299-303.\nAkintunde EO, Shokunbi WA, Adekunle CO. Leucocyte count, platelet count and erythrocyte sedimentation rate in pulmonary tuberculosis. Afr J Med Med Sci 1995; 24: 131-134.\nCopaitich T. [Behavior of erythrocyte sedimentation rate in meningeal tuberculosis treated with isoniazid.]. Lotta Tuberc 1955; 25: 170- 178.\nMehrotra MP, Agrawal AN. Erythrocyte sedimentation rate in abdominal tuberculosis. In- dian Pract 1967; 20: 217-218.\n[https://doi.org/10.1136/bmj.3.5559.218](https://doi.org/10.1136/bmj.3.5559.218)\nTanaka T. Clinical and statistical survey of the red blood sedimentation rate in tuberculous pleurisy with effusion. Kekkaku 1950; 25: 623- 629.\nTanaka T. Clinical study of tuberculin reaction in the tuberculous exudative pleurisy; its relation to the red blood sedimentation rate. Ke- kkaku 1951; 26: 94-97; English Transl, 45.\nTanaka T. Tuberculous exudative pleurisy observed before and during the war in relation to the blood sedimentation rate. Kekkaku 1951; 26: 106-114; English transl 244-105.\nSarkar K, Baraily S, Dasgupta S, Bhattacharya SK. Erythrocyte sedimentation rate may be an indicator for screening of tuberculosis patients for underlying HIV infection, particularly in re- source-poor settings: an experience from India. J Health Popul Nutr 2004; 22: 220-221.\nUkpe IS, Southern L. Erythrocyte sedimentation rate values in active tuberculosis with and without HIV co-infection. S Afr Med J 2006; 96: 427-428.\nFitzgerald D, Haas DW. Mycobacterium tuber- culosis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases (ed Sixth edition). Philadelphhia, PA: Elseiver, Inc; 2005: 2852-2886.\nMcCarthy PL, Tomasso L, Dolan TF, Jr. Predicting fever response of children with pneumonia treated with antibiotics. Clin Pediatr (Phila) 1980; 19: 753-760.\n[https://doi.org/10.1177/000992288001901108](https://doi.org/10.1177/000992288001901108)\nHolmberg H, Bodin L, Jonsson I, Krook A. Rapid aetiological diagnosis of pneumonia based on routine laboratory features. Scand J Infect Dis 1990; 22: 537-545.\n[https://doi.org/10.3109/00365549009027093](https://doi.org/10.3109/00365549009027093)\nTriga MG, Syrogiannopoulos GA, Thoma KD, Fezoulidis IB, Pastromas VG, Beratis NG. Correlation of leucocyte count and erythrocyte sedimentation rate with the day of illness in presumed bacterial pneumonia of childhood. J Infect 1998; 36: 63-66.\n[https://doi.org/10.1016/S0163-4453(98)93198-X](https://doi.org/10.1016/S0163-4453(98)93198-X)\nKorppi M, Heiskanen-Kosma T, Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococ- cal pneumonia in children. Eur Respir J 1997; 10: 1125-1129.\n[https://doi.org/10.1183/09031936.97.10051125](https://doi.org/10.1183/09031936.97.10051125)\nHopstaken RM, Muris JW, Knottnerus JA, Kes- ter AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract in- fection. Br J Gen Pract 2003; 53: 358-364.\nToikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, et al. Serum procalcitonin, Creactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19: 598-602.\n[https://doi.org/10.1097/00006454-200007000-00003](https://doi.org/10.1097/00006454-200007000-00003)\nNohynek H, Valkeila E, Leinonen M, Eskola J. Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children. Pediatr Infect Dis J 1995; 14: 484-490.\n[https://doi.org/10.1097/00006454-199506000-00004](https://doi.org/10.1097/00006454-199506000-00004)\nSaijo M, Ishii T, Kokubo M, Murono K, Taki- moto M, Fujita K. White blood cell count, C- reactive protein and erythrocyte sedimentation rate in respiratory syncytial virus infection of the lower respiratory tract. Acta Paediatr Jpn 1996; 38: 596-600.\n[https://doi.org/10.1111/j.1442-200X.1996.tb03714.x](https://doi.org/10.1111/j.1442-200X.1996.tb03714.x)\nPrag J, Nielsen M, Horlyk H, Ibsen KK, Friis- Moller A, Peitersen B, et al. Micromethod erythrocyte sedimentation rate as a diagnostic tool in neonatal bacterial infections. Dan Med Bull 1984; 31: 483-486.\nOkolo AA, Scott-Emuakpor AB, Omene JA. The diagnostic value of leukocyte indices and micro-erythrocyte sedimentation rate in neona- tal infections. Trop Geogr Med 1988; 40: 304- 308.\nGiannacopoulou C, Hatzidaki E, Kokori H, Giannacopoulos K, Margari KM, Manoura A, et al. Evaluation of the microerythrocyte sedimentation rate in relation to hemoglobin and hematocrit in newborn infections. Haematologia (Budap) 2000; 30: 215-220.\n[https://doi.org/10.1163/156855900300109224](https://doi.org/10.1163/156855900300109224)\nParida SN, Verma IC, Singh MB, Thomas S. Evaluation of micro erythrocyte sedimentation rate in the diagnosis of neonatal sepsis. Indian J Pediatr 1980; 47: 381-384.\n[https://doi.org/10.1007/BF02759832](https://doi.org/10.1007/BF02759832)\nAkpede GO, Abiodun PO. The micro-erythrocyte sedimentation rate as a screening test for bacteraemia in young children with non-focal infections. West Afr J Med 1995; 14: 147-151.\nPutto A, Ruuskanen O, Meurman O, Ekblad H, Korvenranta H, Mertsola J, et al. C reactive protein in the evaluation of febrile illness. Arch Dis Child 1986; 61: 24-29.\n[https://doi.org/10.1136/adc.61.1.24](https://doi.org/10.1136/adc.61.1.24)\nTejani NR, Chonmaitree T, Rassin DK, Howie VM, Owen MJ, Goldman AS. Use of C-reactive protein in differentiation between acute bacterial and viral otitis media. Pediatrics 1995; 95: 664-669.\nCharles D. Value of the erythrocyte sedimentation rate in gynecologic infections. Clin Obstet Gynecol 1976; 19: 171-193.\n[https://doi.org/10.1097/00003081-197603000-00014](https://doi.org/10.1097/00003081-197603000-00014)\nPeltola H, Ahlqvist J, Rapola J, Rasanen J, Louhimo I, Saarinen M, et al. C-reactive protein compared with white blood cell count and erythrocyte sedimentation rate in the diagnosis of acute appendicitis in children. Acta Chir Scand 1986; 152: 55-58.\nvan Dieijen-Visser MP, Go PM, Brombacher PJ. The value of laboratory tests in patients suspected of acute appendicitis. Eur J Clin Chem Clin Biochem 1991; 29: 749-752.\n[https://doi.org/10.1515/cclm.1991.29.11.749](https://doi.org/10.1515/cclm.1991.29.11.749)\nOosterhuis WP, Zwinderman AH, Teeuwen M, van Andel G, Oldenziel H, Kerkhoff JF, et al. C reactive protein in the diagnosis of acute appendicitis. Eur J Surg 1993; 159: 115-119.\nMiettinen AK, Heinonen PK, Laippala P, Pa- avonen J. Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol 1993; 169: 1143- 1149.\n[https://doi.org/10.1016/0002-9378(93)90271-J](https://doi.org/10.1016/0002-9378(93)90271-J)\nReljic M, Gorisek B. C-reactive protein and the treatment of pelvic inflammatory disease. Int J Gynaecol Obstet 1998; 60: 143-150.\n[https://doi.org/10.1016/S0020-7292(97)00236-1](https://doi.org/10.1016/S0020-7292(97)00236-1)\nAlbu E, Miller BM, Choi Y, Lakhanpal S, Mur- thy RN, Gerst PH. Diagnostic value of C-reactive protein in acute appendicitis. Dis Colon Rectum 1994; 37: 49-51.\n[https://doi.org/10.1007/BF02047214](https://doi.org/10.1007/BF02047214)\nGurleyik E, Gurleyik G, Unalmiser S. Accuracy of serum C-reactive protein measurements in diagnosis of acute appendicitis compared with surgeon's clinical impression. Dis Colon Rectum 1995; 38: 1270-1274.\n[https://doi.org/10.1007/BF02049151](https://doi.org/10.1007/BF02049151)\nHallan S, Asberg A. The accuracy of C-reactive protein in diagnosing acute appendicitis--a meta-analysis. Scand J Clin Lab Invest 1997; 57: 373-380.\n[https://doi.org/10.3109/00365519709084584](https://doi.org/10.3109/00365519709084584)\nAndersson RE, Hugander A, Ravn H, Offenbartl K, Ghazi SH, Nystrom PO, et al. Repeated clinical and laboratory examinations in patients with an equivocal diagnosis of appendicitis. World J Surg 2000; 24: 479-485; discussion 485.\n[https://doi.org/10.1007/s002689910076](https://doi.org/10.1007/s002689910076)\nYang HR, Wang YC, Chung PK, Chen WK, Jeng LB, Chen RJ. Role of leukocyte count, neutrophil percentage, and C-reactive protein in the diagnosis of acute appendicitis in the elderly. Am Surg 2005; 71: 344-347.\n[https://doi.org/10.1177/000313480507100414](https://doi.org/10.1177/000313480507100414)\nShafi SM, Afsheen M, Reshi FA. Total leucocyte count, C-reactive protein and neutrophil count: diagnostic aid in acute appendicitis. Saudi J Gastroenterol 2009; 15: 117-120.\n[https://doi.org/10.4103/1319-3767.48969](https://doi.org/10.4103/1319-3767.48969)\nTruswell AS. The erythrocyte sedimentation rate in typhoid. S Afr Med J 1958; 32: 381-383.\n[https://doi.org/10.2307/40097967](https://doi.org/10.2307/40097967)\nAgnew S, Spink WW. The erythrocyte sedimentation rate in brucellosis. Am J Med Sci 1949; 217: 211-214.\n[https://doi.org/10.1097/00000441-194902000-00014](https://doi.org/10.1097/00000441-194902000-00014)\nSyrjala H. Peripheral blood leukocyte counts, erythrocyte sedimentation rate and C-reactive protein in tularemia caused by the type B strain of Francisella tularensis. Infection 1986; 14: 51- 54.\n[https://doi.org/10.1007/BF01644441](https://doi.org/10.1007/BF01644441)\nMehta SH, Shih R. Cervical epidural abscess associated with massively elevated erythrocyte sedimentation rate. J Emerg Med 2004; 26: 107-109.\n[https://doi.org/10.1016/j.jemermed.2003.04.006](https://doi.org/10.1016/j.jemermed.2003.04.006)\nSevinc A, Bayindir Y, But A. The knocked-out erythrocyte sedimentation rate: periodontal abscess. Clin Lab 2008; 54: 15-18.\nPeltola H, Vahvanen V, Aalto K. Fever, C-reactive protein, and erythrocyte sedimentation rate in monitoring recovery from septic arthritis: a preliminary study. J Pediatr Orthop 1984; 4: 170-174.\n[https://doi.org/10.1097/01241398-198403000-00004](https://doi.org/10.1097/01241398-198403000-00004)\nKallio MJ, Unkila-Kallio L, Aalto K, Peltola H. Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J 1997; 16: 411-413.\n[https://doi.org/10.1097/00006454-199704000-00015](https://doi.org/10.1097/00006454-199704000-00015)\nHellgren U, Julander I. Are white blood cell count, platelet count, erythrocyte sedimentation rate and C-reactive protein useful in the diagnosis of septicaemia and endocarditis? Scand J Infect Dis 1986; 18: 487-488.\n[https://doi.org/10.3109/00365548609032370](https://doi.org/10.3109/00365548609032370)\nHogevik H, Olaison L, Andersson R, Alestig K. C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection 1997; 25: 82-85.\n[https://doi.org/10.1007/BF02113580](https://doi.org/10.1007/BF02113580)\nCheah JS, Ransome GA. The erythrocyte sedimentation rate in leptospirosis. Med J Aust 1971; 1: 1233-1234.\n[https://doi.org/10.5694/j.1326-5377.1971.tb50309.x](https://doi.org/10.5694/j.1326-5377.1971.tb50309.x)\nSun HL, Hu CK. Differential erythrocyte sedimentation rate in the diagnosis of syphilis: a pr liminary report. Chin Med J 1951; 69: 46-51.\nFowler W. The erythrocyte sedimentation rate in syphilis. Br J Vener Dis 1976; 52: 309-312.\n[https://doi.org/10.1136/sti.52.5.309](https://doi.org/10.1136/sti.52.5.309)\nKalayanarooj S, Nimmannitya S. A study of erythrocyte sedimentation rate in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1989; 20: 325-330.\nSouza LJ, Reis AF, de Almeida FC, Souza LA, Abukater M, Gomes MA, et al. Alteration in the erythrocyte sedimentation rate in dengue patients: analysis of 1,398 cases. Braz J Infect Dis 2008; 12: 472-475.\n[https://doi.org/10.1590/S1413-86702008000600005](https://doi.org/10.1590/S1413-86702008000600005)\nLaha PN. Erythrocyte sedimentation rate in coma caused by infective hepatitis. J Indian Med Assoc 1959; 33: 416-419.\nKinghorn GR, Turner EB. Value of the erythrocyte sedimentation rate in primary genital her- pes. Br J Clin Pract 1978; 32: 49-51, 55.\nNdakotsu MA, Salawu L, Durosinmi MA. Relation between erythrocyte sedimentation rate, clinical and immune status in HIV-infected patients. Niger J Med 2008; 17: 420-422.\n[https://doi.org/10.4314/njm.v17i4.37425](https://doi.org/10.4314/njm.v17i4.37425)\nNdakotsu MA, Salawu L, Durosinmi MA. Relation between erythrocyte sedimentation rate, clinical and immune status in HIV-infected patients. Niger J Med 2009; 18: 208-210.\n[https://doi.org/10.4314/njm.v18i2.45067](https://doi.org/10.4314/njm.v18i2.45067)\nSawada S, Mitamura K, Takei M, Okubo T, Fujiwara S. Soluble CD23 levels and their correlation with erythrocyte sedimentation rate and with copy number of Epstein-Barr virus genome in rheumatoid arthritis patients. Clin Rheumatol 1997; 16: 635-636.\n[https://doi.org/10.1007/BF02247809](https://doi.org/10.1007/BF02247809)\nChaudhary SK, Chaudhary S, Saxena SK. Raised erythrocyte sedimentation rate (ESR) in hydatid disease. Trans R Soc Trop Med Hyg 1983; 77: 159.\n[https://doi.org/10.1016/0035-9203(83)90055-X](https://doi.org/10.1016/0035-9203(83)90055-X)\nEriksson B, Hellgren U, Rombo L. Changes in erythrocyte sedimentation rate, C-reactive protein and hematological parameters in patients with acute malaria. Scand J Infect Dis 1989; 21: 434-441.\n[https://doi.org/10.3109/00365548909167449](https://doi.org/10.3109/00365548909167449)\nRoehm DC. Trichinosis; report of case manifesting myocarditis, encephalitis and radial neuritis; response to ACTH; review of literature regarding the erythrocyte sedimentation rate. Ann Intern Med 1954; 40: 1026-1040.\n[https://doi.org/10.7326/0003-4819-40-5-1026](https://doi.org/10.7326/0003-4819-40-5-1026)\nOkamura JM, Miyagi JM, Terada K, Hokama Y. Potential clinical applications of C-reactive protein. J Clin Lab Anal 1990; 4: 231-235.\n[https://doi.org/10.1002/jcla.1860040316](https://doi.org/10.1002/jcla.1860040316)\nArnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Ar- thritis Rheum 1988; 31: 315-324.\n[https://doi.org/10.1002/art.1780310302](https://doi.org/10.1002/art.1780310302)\nWoodmansey A, Wilson JV. A method for measuring plasma viscosity and a comparison of plasma viscosity with blood sedimentation rate in rheumatoid arthritis. Ann Rheum Dis 1948; 7: 235-238.\n[https://doi.org/10.1136/ard.7.4.235](https://doi.org/10.1136/ard.7.4.235)\nCrockson RA, Crockson AP. Relationship of the erythrocyte sedimentation rate to viscosity and plasma proteins in rheumatoid arthritis. Ann Rheum Dis 1974; 33: 53-56.\n[https://doi.org/10.1136/ard.33.1.53](https://doi.org/10.1136/ard.33.1.53)\nAylward M, Maddock J, Wheeldon R, Parker RJ. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis. Rheumatol Rehabil 1975; 14: 101-114.\n[https://doi.org/10.1093/rheumatology/14.2.101](https://doi.org/10.1093/rheumatology/14.2.101)\nPatberg WR. Correlation of erythrocyte sedimentation rate and outdoor temperature in a patient with rheumatoid arthritis. J Rheumatol 1997; 24: 1017-1018.\nPaulus HE, Brahn E. Is erythrocyte sedimentation rate the preferable measure of the acute phase response in rheumatoid arthritis? J Rheu- matol 2004; 31: 838-840.\nYazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol 2004; 31: 1723-1726.\nWalsh L, Davies P, McConkey B. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 362-363.\n[https://doi.org/10.1136/ard.38.4.362](https://doi.org/10.1136/ard.38.4.362)\nCohick CB, Furst DE, Quagliata S, Corcoran KA, Steere KJ, Yager JG, et al. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein. J Lab Clin Med 1994; 123: 721-727.\nWolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997; 24: 1477-1485.\nGraudal N, Tarp U, Jurik AG, Galloe AM, Garred P, Milman N, et al. Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progres- sion. J Rheumatol 2000; 27: 47-57.\nSkogh T, Gustafsson D, Kjellberg M, Husberg M. Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate. Ann Rheum Dis 2003; 62: 681-682.\n[https://doi.org/10.1136/ard.62.7.681](https://doi.org/10.1136/ard.62.7.681)\nWard MM. Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis. J Rheumatol 2004; 31: 884-895.\nSim\u00f3n-Campos JA, Padilla-Hern\u00e1ndez RO. [Correlation between C reactive protein and erythrosedimentation rate with rheumatoid arthritis disease activity]. Rev Med Inst Mex Seguro Soc 2008; 46: 591-596.\nShovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Orbach H, Gerli R, et al. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Clin Dev Immunol 2005; 12: 197-202.\n[https://doi.org/10.1080/17402520500233510](https://doi.org/10.1080/17402520500233510)\nWu JF, Yang YH, Wang LC, Lee JH, Shen EY, Chiang BL. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis. Clin Exp Rheuma- tol 2007; 25: 782-785.\nKalliomaki L. Correlation of the erythrocyte sedimentation rate and gold complications in rheumatoid arthritis. Ann Rheum Dis 1954; 13: 336-337.\n[https://doi.org/10.1136/ard.13.4.336](https://doi.org/10.1136/ard.13.4.336)\nMaddock J, Rees P, Holly F, Aylward M. The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis. Curr Med Res Opin 1975; 3: 286-297.\n[https://doi.org/10.1185/03007997509114779](https://doi.org/10.1185/03007997509114779)\nAmos RS, Crockson RA, Crockson AP, Walsh L, McConkey B. Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate du- ring initial treatment. Br Med J 1978; 1: 1396.\n[https://doi.org/10.1136/bmj.1.6124.1396](https://doi.org/10.1136/bmj.1.6124.1396)\nMcConkey B, Davies P, Crockson RA, Crock- son AP, Butler M, Constable TJ, et al. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 141-144.\n[https://doi.org/10.1136/ard.38.2.141](https://doi.org/10.1136/ard.38.2.141)\nGrimaldi MG. Long-term low dose ticlopidine treatment in rheumatoid arthritis: effects on serum sulphydryl levels, technetium index, erythrocyte sedimentation rate, and clinical disease activity. Eur J Clin Pharmacol 1985; 29: 165-168.\n[https://doi.org/10.1007/BF00547416](https://doi.org/10.1007/BF00547416)\nMcConkey B, Amos RS, Billingham ME, Cons- table TJ, Crockson RA, Crockson AP, et al. Rheumatoid arthritis: effects of a new agent (ICI 55 897) on serum acute phase proteins and the erythrocyte sedimentation rate. Ann Rheum Dis 1980; 39: 18-21.\n[https://doi.org/10.1136/ard.39.1.18](https://doi.org/10.1136/ard.39.1.18)\nDawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces ra- diological progression. Br J Rheumatol 1986; 25: 44-49.\n[https://doi.org/10.1093/rheumatology/25.1.44](https://doi.org/10.1093/rheumatology/25.1.44)\nKelly CA, McClelland J, Fail B, Walker D. Erythrocyte sedimentation rate, plasma and serum viscosity as measures of disease activity in rheumatoid arthritis. Br J Rheumatol 1987; 26: 136-138.\n[https://doi.org/10.1093/rheumatology/26.2.136](https://doi.org/10.1093/rheumatology/26.2.136)\nMallya RK, de Beer FC, Berry H, Hamilton ED, Mace BE, Pepys MB. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 1982; 9: 224-228.\nAmos RS, Constable TJ, Crockson RA, Crock- son AP, McConkey B. Rheumatoid arthritis: rela- tion of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J 1977; 1: 195-197.\n[https://doi.org/10.1136/bmj.1.6055.195](https://doi.org/10.1136/bmj.1.6055.195)\nMatsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response crite- ria compared with DAS28 using erythrocyte se- dimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 2007; 66: 1221-1226.\n[https://doi.org/10.1136/ard.2006.063834](https://doi.org/10.1136/ard.2006.063834)\nYoung B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991; 23: 118-124.\n[https://doi.org/10.3109/00313029109060809](https://doi.org/10.3109/00313029109060809)\nAlexander WD, Andrews MM. Discrepancies in the erythrocyte-sedimentation test in rheumatic fever. Lancet 1957; 272: 240-242.\n[https://doi.org/10.1016/S0140-6736(57)90300-8](https://doi.org/10.1016/S0140-6736(57)90300-8)\nHarris TN, Friedman S, Tang J. Paradoxical values of the erythrocyte sedimentation rate in rheumatic fever: a comparison among three acute phase tests. Am J Med Sci 1957; 234: 259-268 passim.\nIllingworth RS. Cortisone treatment of rheumatic fever; relationship of weight to the speed of fall of erythrocyte-sedimentation rate. Lancet 1957; 273: 659-660.\n[https://doi.org/10.1016/S0140-6736(57)92105-0](https://doi.org/10.1016/S0140-6736(57)92105-0)\nEastham RD, Szekely P, Davison K. Comparison of the erythrocyte sedimentation rate, C-reactive protein, serum diphenylamine, and tetrammonium tests in rheumatic fever and rheumatic heart disease. Ann Rheum Dis 1958; 17: 319-325.\n[https://doi.org/10.1136/ard.17.3.319](https://doi.org/10.1136/ard.17.3.319)\nRozansky R, Davis E. Relation between C-reactive protein and erythrocyte sedimentation rate in rheumatic fever. Am J Clin Pathol 1958; 29: 331-333.\n[https://doi.org/10.1093/ajcp/29.4.331](https://doi.org/10.1093/ajcp/29.4.331)\nCoburn AF, Kapp EM. Observations on the development of the high blood sedimentation rate in rheumatic carditis. J Clin Invest 1936; 15: 715-723.\n[https://doi.org/10.1172/JCI100825](https://doi.org/10.1172/JCI100825)\nGuidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992; 268: 2069-2073.\n[https://doi.org/10.1001/jama.268.15.2069](https://doi.org/10.1001/jama.268.15.2069)\nHunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The Ame- rican College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128.\n[https://doi.org/10.1002/art.1780330810](https://doi.org/10.1002/art.1780330810)\nFauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med 1972; 77: 845-852.\n[https://doi.org/10.7326/0003-4819-77-6-845](https://doi.org/10.7326/0003-4819-77-6-845)\nHuston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978; 88: 162-167.\n[https://doi.org/10.7326/0003-4819-88-2-162](https://doi.org/10.7326/0003-4819-88-2-162)\nPark JR, Jones JG, Hazleman BL. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1981; 40: 493-495.\n[https://doi.org/10.1136/ard.40.5.493](https://doi.org/10.1136/ard.40.5.493)\nBranum G, Massey EW, Rice J. Erythrocyte sedimentation rate in temporal arteritis. South Med J 1987; 80: 1527-1528.\n[https://doi.org/10.1097/00007611-198712000-00010](https://doi.org/10.1097/00007611-198712000-00010)\nJacobson DM, Slamovits TL. Erythrocyte sedimentation rate and its relationship to hematocrit in giant cell arteritis. Arch Ophthalmol 1987; 105: 965-967.\n[https://doi.org/10.1001/archopht.1987.01060070101037](https://doi.org/10.1001/archopht.1987.01060070101037)\nLove DC, Berler DK, O'Dowd GJ, Brooks JZ, Love RA. Erythrocyte sedimentation rate and its relationship to hematocrit giant cell arteritis. Arch Ophthalmol 1988; 106: 309-310.\n[https://doi.org/10.1001/archopht.1988.01060130335006](https://doi.org/10.1001/archopht.1988.01060130335006)\nKyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989; 48: 667-671.\n[https://doi.org/10.1136/ard.48.8.667](https://doi.org/10.1136/ard.48.8.667)\nBrittain GP, McIlwaine GG, Bell JA, Gibson JM. Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis? Br J Ophthalmol 1991; 75: 656-659.\n[https://doi.org/10.1136/bjo.75.11.656](https://doi.org/10.1136/bjo.75.11.656)\nMurphy PT, Allen B, Hutchinson RM. Plasma viscosity and erythrocyte sedimentation rate in suspected cases of temporal arteritis. Br J Haematol 1994; 87: 671.\n[https://doi.org/10.1111/j.1365-2141.1994.tb08342.x](https://doi.org/10.1111/j.1365-2141.1994.tb08342.x)\nPountain GD, Calvin J, Hazleman BL. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1994; 33: 550-554.\n[https://doi.org/10.1093/rheumatology/33.6.550](https://doi.org/10.1093/rheumatology/33.6.550)\nDiaz VA, DeBroff BM, Sinard J. Comparison of histopathologic features, clinical symptoms, and erythrocyte sedimentation rates in biopsy-positive temporal arteritis. Ophthalmology 2005; 112: 1293-1298.\n[https://doi.org/10.1016/j.ophtha.2005.02.016](https://doi.org/10.1016/j.ophtha.2005.02.016)\nParikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 2006; 113: 1842-1845.\n[https://doi.org/10.1016/j.ophtha.2006.05.020](https://doi.org/10.1016/j.ophtha.2006.05.020)\nLopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Pena-Sagredo JL, Martin J, Gonzalez-Gay MA. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum 2008; 38: 116-123.\n[https://doi.org/10.1016/j.semarthrit.2007.10.014](https://doi.org/10.1016/j.semarthrit.2007.10.014)\nVillalta J, Estrach T. Temporal arteritis with normal erythrocyte sedimentation rate. Ann Intern Med 1985; 103: 808.\n[https://doi.org/10.7326/0003-4819-103-5-808_2](https://doi.org/10.7326/0003-4819-103-5-808_2)\nWong RL, Korn JH. Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med 1986; 80: 959-964.\n[https://doi.org/10.1016/0002-9343(86)90645-5](https://doi.org/10.1016/0002-9343(86)90645-5)\nBlumenthal HJ. Temporal arteritis without an elevated erythrocyte sedimentation rate. Am J Med 1987; 82: 187.\n[https://doi.org/10.1016/0002-9343(87)90414-1](https://doi.org/10.1016/0002-9343(87)90414-1)\nBerth-Jones J, Holt PJ. Temporal arteritis presen- ting with scalp necrosis and a normal erythrocyte sedimentation rate. Clin Exp Dermatol 1988; 13: 200-201.\n[https://doi.org/10.1111/j.1365-2230.1988.tb01971.x](https://doi.org/10.1111/j.1365-2230.1988.tb01971.x)\nGrodum E, Petersen HA. Temporal arteritis with normal erythrocyte sedimentation rate. J Intern Med 1990; 227: 279-280.\n[https://doi.org/10.1111/j.1365-2796.1990.tb00158.x](https://doi.org/10.1111/j.1365-2796.1990.tb00158.x)\nGaniats TG. Temporal arteritis with normal erythrocyte sedimentation rate. J Am Board Fam Pract 1991; 4: 119-122.\nJundt JW, Mock D. Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum 1991; 34: 217-219.\n[https://doi.org/10.1002/art.1780340214](https://doi.org/10.1002/art.1780340214)\nWise CM, Agudelo CA, Chmelewski WL, Mc- Knight KM. Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum 1991; 34: 1571-1574.\n[https://doi.org/10.1002/art.1780341215](https://doi.org/10.1002/art.1780341215)\nFielding DI, Brown IG. Temporal arteritis in a young patient with a normal erythrocyte sedimentation rate. Aust N Z J Med 1994; 24: 66- 67.\n[https://doi.org/10.1111/j.1445-5994.1994.tb04430.x](https://doi.org/10.1111/j.1445-5994.1994.tb04430.x)\nPolak P, Pokorny V, Stvrtina S, Tauchmanno- va H, Malis F, Rovensky J. Temporal arteritis presenting with paresis of the oculomotor nerve, and polymyalgia rheumatica, despite a low erythrocyte sedimentation rate. J Clin Rheuma- tol 2005; 11: 242-244.\n[https://doi.org/10.1097/01.rhu.0000173621.55149.d6](https://doi.org/10.1097/01.rhu.0000173621.55149.d6)\nCiccarelli M, Jeanmonod D, Jeanmonod R. Giant cell temporal arteritis with a normal erythrocyte sedimentation rate: report of a case. Am J Emerg Med 2009; 27: 255 e251-253.\n[https://doi.org/10.1016/j.ajem.2008.06.032](https://doi.org/10.1016/j.ajem.2008.06.032)\nBird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434-439.\n[https://doi.org/10.1136/ard.38.5.434](https://doi.org/10.1136/ard.38.5.434)\nEsselinckx W, Bucknall RC, Dixon AS. Polymyalgia rheumatica. Assessment of disease activity using erythrocyte sedimentation rate and plasma viscosity. Ann Rheum Dis 1977; 36: 560-562.\n[https://doi.org/10.1136/ard.36.6.560](https://doi.org/10.1136/ard.36.6.560)\nPapadakis MA, Schwartz ND. Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica. Arch Intern Med 1986; 146: 2283-2284.\n[https://doi.org/10.1001/archinte.1986.00360230229033](https://doi.org/10.1001/archinte.1986.00360230229033)\nPountain G, Hazleman B. Erythrocyte sedimentation rate (ESR) at presentation is a prognostic indicator for duration of treatment in polymyalgia rheumatica (PMR). Br J Rheumatol 1997; 36: 508-509.\n[https://doi.org/10.1093/rheumatology/36.4.508b](https://doi.org/10.1093/rheumatology/36.4.508b)\nCantini F, Salvarani C, Olivieri I. Erythrocyte sedimentation rate and C-reactive protein in the diagnosis of polymyalgia rheumatica. Ann Intern Med 1998; 128: 873-874.\n[https://doi.org/10.7326/0003-4819-128-10-199805150-00021](https://doi.org/10.7326/0003-4819-128-10-199805150-00021)\nCantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 2000; 30: 17-24.\n[https://doi.org/10.1053/sarh.2000.8366](https://doi.org/10.1053/sarh.2000.8366)\nVila LM, Alarcon GS, McGwin G, Jr., Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort (LUMI- NA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 2005; 32: 2150- 2155.\nRuof J, Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 1999; 26: 966-970.\nSpoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999; 26: 980-984.\nHelliwell PS, Marchesoni A, Peters M, Platt R, Wright V. Cytidine deaminase activity, C reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis. Ann Rheum Dis 1991; 50: 362-365.\n[https://doi.org/10.1136/ard.50.6.362](https://doi.org/10.1136/ard.50.6.362)\nRoss R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115-126.\n[https://doi.org/10.1056/NEJM199901143400207](https://doi.org/10.1056/NEJM199901143400207)\nCairncross D, Collins GM, Kostalas G, Ludbrook J. Blood viscosity and erythrocyte sedimentation rate in patients with thrombotic arte- rial disorders. Med J Aust 1969; 1: 1348-1352.\n[https://doi.org/10.5694/j.1326-5377.1969.tb62400.x](https://doi.org/10.5694/j.1326-5377.1969.tb62400.x)\nRafnsson V, Bengtsson C. Erythrocyte sedimentation rate and cardiovascular disease. Results from a population study of women in Goteborg, Sweden. Atherosclerosis 1982; 42: 97-107.\n[https://doi.org/10.1016/0021-9150(82)90130-7](https://doi.org/10.1016/0021-9150(82)90130-7)\nFusman G, Mardi T, Justo D, Rozenblat M, Rotstein R, Zeltser D, et al. Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol 2002; 90: 561-563.\n[https://doi.org/10.1016/S0002-9149(02)02539-0](https://doi.org/10.1016/S0002-9149(02)02539-0)\nBottiger LE, Carlson LA, Ekelund LG, Olsson AG. Raised erythrocyte sedimentation rate in asymptomatic hyperlipidaemia. Br Med J 1973; 2: 681-684.\n[https://doi.org/10.1136/bmj.2.5868.681](https://doi.org/10.1136/bmj.2.5868.681)\nWardle EN. Erythrocyte sedimentation rate in hyperlipidaemia. Br Med J 1973; 3: 109.\n[https://doi.org/10.1136/bmj.3.5871.109-b](https://doi.org/10.1136/bmj.3.5871.109-b)\nChoi JW, Pai SH. Influences of hypercholesterolemia on red cell indices and erythrocyte sedimentation rate in elderly persons. Clin Chim Acta 2004; 341: 117-121.\n[https://doi.org/10.1016/j.cccn.2003.11.013](https://doi.org/10.1016/j.cccn.2003.11.013)\nKhachadurian AK, Demirjian ZN. Persistent elevation of the erythrocyte sedimentation rate (ESR) in familial hypercholesterolemia. With a preliminary report on the effect of plasma beta- lipoproteins on ESR. J Med Liban 1967; 20: 31- 43.\nBalestrino M, Partinico D, Finocchi C, Gandol- fo C. White blood cell count and erythrocyte sedimentation rate correlate with outcome in patients with acute ischemic stroke. J Stroke Ce- rebrovasc Dis 1998; 7: 139-144.\n[https://doi.org/10.1016/S1052-3057(98)80141-9](https://doi.org/10.1016/S1052-3057(98)80141-9)\nZaremba J, Skrobanski P, Losy J. Acute ischae- mic stroke increases the erythrocyte sedimentation rate, which correlates with early brain damage. Folia Morphol (Warsz) 2004; 63: 373- 376.\nSwartz JE, Jacobson BF, Connor MD, Bernstein PL, Fritz VU. Erythrocyte sedimentation rate as a marker of inflammation and ongoing coagulation in stroke and transient ischaemic attack. S Afr Med J 2005; 95: 607-612.\nChamorro A, Vila N, Ascaso C, Saiz A, Montal- vo J, Alonso P, et al. Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. Stroke 1995; 26: 573-576.\n[https://doi.org/10.1161/01.STR.26.4.573](https://doi.org/10.1161/01.STR.26.4.573)\nGillum RF, Sempos CT. Erythrocyte sedimenta- tion rate and stroke incidence in the NHANES I Epidemiologic Follow-up Study. Stroke 1997; 28: 873-874.\nDe Silva DA, Woon FP, Gan HY, Chen C, Chang HM, Cameron J, et al. Arterial stiffness is associated with raised levels of the inflammatory marker erythrocyte sedimentation rate among ischaemic stroke patients. Intern Med J 2008; 38: 918-920.\n[https://doi.org/10.1111/j.1445-5994.2008.01811.x](https://doi.org/10.1111/j.1445-5994.2008.01811.x)\nWu LA, Tan SL, Wright RS, Kopecky SL, Burritt MF, Santrach PJ, et al. Prognostic value of the erythrocyte sedimentation rate in patients with unstable angina. Arch Pathol Lab Med 2002; 126: 772.\n[https://doi.org/10.5858/2002-126-0772-PVOTES](https://doi.org/10.5858/2002-126-0772-PVOTES)\nKirkeby OJ, Risoe C. Erythrocyte sedimentation rate and coronary heart disease in elderly patients. J Oslo City Hosp 1986; 36: 93-94.\nGillum RF, Mussolino ME, Makuc DM. Erythrocyte sedimentation rate and coronary heart di- sease: the NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 1995; 48: 353-361.\n[https://doi.org/10.1016/0895-4356(94)00156-K](https://doi.org/10.1016/0895-4356(94)00156-K)\nDanesh J, Collins R, Peto R, Lowe GD. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000; 21: 515-520.\n[https://doi.org/10.1053/euhj.1999.1699](https://doi.org/10.1053/euhj.1999.1699)\nErikssen G, Liestol K, Bjornholt JV, Stormorken H, Thaulow E, Erikssen J. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. Eur Heart J 2000; 21: 1614-1620.\n[https://doi.org/10.1053/euhj.2000.2148](https://doi.org/10.1053/euhj.2000.2148)\nRapaport E. Erythrocyte sedimentation rate: is it a useful risk marker for coronary heart disease? Eur Heart J 2000; 21: 1567-1569.\n[https://doi.org/10.1053/euhj.2000.2236](https://doi.org/10.1053/euhj.2000.2236)\nAndresdottir MB, Sigfusson N, Sigvaldason H, Gudnason V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study. Am J Epidemiol 2003; 158: 844-851.\n[https://doi.org/10.1093/aje/kwg222](https://doi.org/10.1093/aje/kwg222)\nNatali A, L'Abbate A, Ferrannini E. Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J 2003; 24: 639-648.\n[https://doi.org/10.1016/S0195-668X(02)00741-8](https://doi.org/10.1016/S0195-668X(02)00741-8)\nGodsland IF, Bruce R, Jeffs JA, Leyva F, Walton C, Stevenson JC. Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study. Int J Cardiol 2004; 97: 543-550.\n[https://doi.org/10.1016/j.ijcard.2004.05.008](https://doi.org/10.1016/j.ijcard.2004.05.008)\nLosner S, Volk BW, Wilensky ND. Fibrinogen concentration in acute myocardial infarction; comparison of the clot density determination of fibrinogen with the erythrocyte sedimentation rate. AMA Arch Intern Med 1954; 93: 231- 245.\n[https://doi.org/10.1001/archinte.1954.00240260067006](https://doi.org/10.1001/archinte.1954.00240260067006)\nVolk BW, Losner S. The erythrocyte sedimentation rate in hemoconcentration associated with acute myocardial infarction. Am Heart J 1954; 47: 658-663.\n[https://doi.org/10.1016/0002-8703(54)90190-8](https://doi.org/10.1016/0002-8703(54)90190-8)\nBurstein J. The significance of prolonged elevation of the sedimentation rate caused by myocardial infarction; prognosis and therapeutical aspects. Acta Med Scand 1956; 155: 457-462.\n[https://doi.org/10.1111/j.0954-6820.1956.tb14394.x](https://doi.org/10.1111/j.0954-6820.1956.tb14394.x)\nBoltax AJ, Fischel EE. Serologic tests for inflammation; serum complement, c-reactive protein and erythrocyte sedimentation rate in myocardial infarction. Am J Med 1956; 20: 418-427.\n[https://doi.org/10.1016/0002-9343(56)90127-9](https://doi.org/10.1016/0002-9343(56)90127-9)\nLinko E, Waris E, Alikoski HA. Plasma protein changes and their influence on the erythrocyte sedimentation rate in myocardial infarction. Acta Med Scand 1956; 153: 389-398.\nHolger-Madsen T. Plasma fibrinogen and erythrocyte sedimentation rate in myocardial infarction. Acta Med Scand 1957; 156: 351-360.\n[https://doi.org/10.1111/j.0954-6820.1957.tb00093.x](https://doi.org/10.1111/j.0954-6820.1957.tb00093.x)\nLadue JS. Laboratory aids in diagnosis of myocardial infarction; changes in muscle enzymes, erythrocyte sedimentation rate, and C-reactive protein in myocardial infarction. J Am Med Assoc 1957; 165: 1776-1781.\n[https://doi.org/10.1001/jama.1957.02980320006003](https://doi.org/10.1001/jama.1957.02980320006003)\nGetzen JH, Perry IS. Erythrocyte sedimentation rate, C-reactive protein and transaminase in acute myocardial infarction. Am Pract Dig Treat 1958; 9: 36-41.\nTimmer JR, Ottervanger JP, Hoorntje JC, De Boer MJ, Suryapranata H, van 't Hof AW, et al. Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia. J Intern Med 2005; 257: 423-429.\n[https://doi.org/10.1111/j.1365-2796.2005.01478.x](https://doi.org/10.1111/j.1365-2796.2005.01478.x)\nAnderson MS, Burns J, Treadwell TA, Pietra BA, Glode MP. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J 2001; 20: 698-702.\n[https://doi.org/10.1097/00006454-200107000-00011](https://doi.org/10.1097/00006454-200107000-00011)\nLee KY, Lee HS, Hong JH, Han JW, Lee JS, Whang KT. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease. J Trop Pediatr 2005; 51: 98-101.\n[https://doi.org/10.1093/tropej/fmh087](https://doi.org/10.1093/tropej/fmh087)\nMcGinnis AE, Lansche WE, Glaser RJ, Loeb LH. Observations on the erythrocyte sedimentation rate in congestive heart failure. Am J Med Sci 1953; 225: 599-604.\n[https://doi.org/10.1097/00000441-195306000-00002](https://doi.org/10.1097/00000441-195306000-00002)\nParry EH. The erythrocyte sedimentation rate in heart failure. Acta Med Scand 1961; 169: 79- 85.\n[https://doi.org/10.1111/j.0954-6820.1961.tb17096.x](https://doi.org/10.1111/j.0954-6820.1961.tb17096.x)\nHaber HL, Leavy JA, Kessler PD, Kukin ML, Gottlieb SS, Packer M. The erythrocyte sedimentation rate in congestive heart failure. N Engl J Med 1991; 324: 353-358.\n[https://doi.org/10.1056/NEJM199102073240601](https://doi.org/10.1056/NEJM199102073240601)\nRuiz-Ruiz FJ, Sierra Bergua B, Flamarique Pascual A, Perez-Calvo J. Prognostic value of erythrocyte sedimentation rate in patients with decompensated heart failure. N Z Med J 2004; 117: U1227.\nIngelsson E, Arnlov J, Sundstrom J, Lind L. Inflammation, as measured by the erythrocyte sedimentation rate, is an independent predictor for the development of heart failure. J Am Coll Cardiol 2005; 45: 1802-1806.\n[https://doi.org/10.1016/j.jacc.2005.02.066](https://doi.org/10.1016/j.jacc.2005.02.066)\nMaradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Jacobsen SJ, Roger VL, et al. Rai- sed erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis. Ann Rheum Dis 2007; 66: 76-80.\n[https://doi.org/10.1136/ard.2006.053710](https://doi.org/10.1136/ard.2006.053710)\nEshaghian J, Goeken JA. C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmology 1980; 87: 1160-1166.\n[https://doi.org/10.1016/S0161-6420(80)35110-5](https://doi.org/10.1016/S0161-6420(80)35110-5)\nSchmidt J, Duhaut P, Bourgeois AM, Salle V, Smail A, Chatelain D, et al. Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study. Rheumatology (Oxford) 2009; 48: 158-159.\n[https://doi.org/10.1093/rheumatology/ken437](https://doi.org/10.1093/rheumatology/ken437)\nDimitrijevic I, Andersson C, Rissler P, Edvins- son L. Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis. Ophthalmology 2010; 117: 628-636.\n[https://doi.org/10.1016/j.ophtha.2009.07.043](https://doi.org/10.1016/j.ophtha.2009.07.043)\nDessein PH, Joffe BI, Stanwix AE. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. J Rheumatol 2004; 31: 1095-1097.\nRidker PM. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem 2009; 55: 209-215.\n[https://doi.org/10.1373/clinchem.2008.119214](https://doi.org/10.1373/clinchem.2008.119214)\nRidker PM. Inflammation, high-sensitivity C- reactive protein, and vascular protection. Tex Heart Inst J 2010; 37: 40-41.\nThynne GS. Plasma carcinoembryonic antigen and erythrocyte sedimentation rate in patients with colorectal carcinoma. Med J Aust 1979; 1: 592-593.\n[https://doi.org/10.5694/j.1326-5377.1979.tb119387.x](https://doi.org/10.5694/j.1326-5377.1979.tb119387.x)\nHarrold BP, Slade PR. The erythrocyte sedimentation rate in carcinoma of the bronchus. Br J Dis Chest 1961; 55: 1-5.\n[https://doi.org/10.1016/S0007-0971(61)80017-X](https://doi.org/10.1016/S0007-0971(61)80017-X)\nRiley V. Breast cancer patients: substance in blood causing acceleration of erythrocyte sedimentation rate. Science 1976; 191: 86-88.\n[https://doi.org/10.1126/science.1246598](https://doi.org/10.1126/science.1246598)\nLane R, Ungerer J, Bernene J, Askenase P. Skin testing and erythrocyte sedimentation rate in women undergoing breast biopsy. Int J Psychiatry Med 1983; 13: 37-46.\n[https://doi.org/10.2190/8D35-C4UE-BWD5-KBX2](https://doi.org/10.2190/8D35-C4UE-BWD5-KBX2)\nImai K, Suzuki T, Kobayashi M, Yamanaka H, Tomaru Y, Sato J. The significance of erythrocyte sedimentation rate as a prognostic factor for patients with prostate cancer: Gunma Urological Oncology Study Group investigation. Jpn J Cancer Res 1990; 81: 971-974.\n[https://doi.org/10.1111/j.13497006.1990.tb03333.x](https://doi.org/10.1111/j.13497006.1990.tb03333.x)\nJohansson JE, Sigurdsson T, Holmberg L, Bergstrom R. Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer. An analysis of prognostic factors in 300 population- based consecutive cases. Cancer 1992; 70: 1556-1563.\n[https://doi.org/10.1002/1097-0142(19920915)70:6](https://doi.org/10.1002/1097-0142(19920915)70:6)<1556::AID-CNCR2820700619>3.0.CO;2-I\nBorre M, Nerstrom B, Overgaard J. Erythrocyte sedimentation rate--a predictor of malignant potential in early prostate cancer. Acta Oncol 1997; 36: 689-694.\n[https://doi.org/10.3109/02841869709001338](https://doi.org/10.3109/02841869709001338)\nSchuhmacher JH, Clorius JH, Semmler W, Hauser H, Matys ER, Maier-Borst W, et al. NMR relaxation times T1 and T2 of water in plasma from patients with lung carcinoma: correlation of T2 with blood sedimentation rate. Magn Reson Med 1987; 5: 537-547.\n[https://doi.org/10.1002/mrm.1910050604](https://doi.org/10.1002/mrm.1910050604)\nJanssen CW, Jr., Maartmann-Moe H, Lie RT. Preoperative prediction of extent and prognosis of gastric carcinoma by four serum proteins and erythrocyte sedimentation rate. Eur J Surg Oncol 1987; 13: 285-295.\nJanssen CW, Jr., Maartmann-Moe H, Lie RT. Concentrations of serum proteins and erythrocyte sedimentation rate in patients with different histological types of gastric carcinoma. Eur J Surg Oncol 1987; 13: 207-211.\nHannisdal E, Bostad L, Grottum KA, Langmark F. Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma. Eur J Surg Oncol 1989; 15: 333-336.\nDonmez T, Kale M, Ozyurek Y, Atalay H. Erythrocyte sedimentation rates in patients with renal cell carcinoma. Eur Urol 1992; 21 Suppl 1: 51-52.\n[https://doi.org/10.1159/000474890](https://doi.org/10.1159/000474890)\nIversen OH, Roger M, Solberg HE, Wetteland P. Rising erythrocyte sedimentation rate during several years before diagnosis can be a predictive factor in 70% of renal cell carcinoma patients. The benefit of knowing subject-based reference values. J Intern Med 1996; 240: 133-141.\n[https://doi.org/10.1046/j.1365-2796.1996.30195852000.x](https://doi.org/10.1046/j.1365-2796.1996.30195852000.x)\nRamsey S, Lamb GW, Aitchison M, McMillan DC. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer. Br J Cancer 2006; 95: 1076-1080.\n[https://doi.org/10.1038/sj.bjc.6603387](https://doi.org/10.1038/sj.bjc.6603387)\nSengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, et al. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer 2006; 106: 304-312.\n[https://doi.org/10.1002/cncr.21617](https://doi.org/10.1002/cncr.21617)\nKarakiewicz PI, Hutterer GC, Trinh QD, Jel- dres C, Perrotte P, Gallina A, et al. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer 2007; 110: 1241- 1247.\n[https://doi.org/10.1002/cncr.22896](https://doi.org/10.1002/cncr.22896)\nReichle A, Grassinger J, Bross K, Wilke J, Suedhoff T, Walter B, et al. C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation. Biomark Insights 2007; 1: 87-98.\n[https://doi.org/10.1177/117727190600100017](https://doi.org/10.1177/117727190600100017)\nKawai Y, Matsuyama H, Korenaga Y, Misumi T, Eguchi S, Hara T, et al. Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma. Urol Int 2009; 83: 306-310.\n[https://doi.org/10.1159/000241673](https://doi.org/10.1159/000241673)\nHrgovcic M, Tessmer CF, Thomas FB, Fuller LM, Gamble JF, Shullenberger CC. Significance of serum copper levels in adult patients with Hodgkin's disease. Cancer 1973; 31: 1337- 1345.\n[https://doi.org/10.1002/1097-0142(197306)31:6](https://doi.org/10.1002/1097-0142(197306)31:6)<1337::AID-CNCR2820310606>3.0.CO;2-W\nLe Bourgeois JP, Tubiana M. The erythrocyte sedimentation rate as a monitor for relapse in patients with previously treated Hodgkin's disease. Int J Radiat Oncol Biol Phys 1977; 2: 241-247.\n[https://doi.org/10.1016/0360-3016(77)90080-3](https://doi.org/10.1016/0360-3016(77)90080-3)\nWagener DJ, Haanen C. Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease. Eur J Clin In- vest 1977; 7: 289-294.\n[https://doi.org/10.1111/j.1365-2362.1977.tb01607.x](https://doi.org/10.1111/j.1365-2362.1977.tb01607.x)\nWilimas J, Thompson E, Smith KL. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease. Cancer 1978; 42: 1929-1935.\n[https://doi.org/10.1002/1097-0142(197810)42:4](https://doi.org/10.1002/1097-0142(197810)42:4)<1929::AID-CNCR2820420435>3.0.CO;2-B\nAsbj\u00f6rnsen G. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease. Scand J Haematol 1979; 22: 193-196.\n[https://doi.org/10.1111/j.1600-0609.1979.tb02796.x](https://doi.org/10.1111/j.1600-0609.1979.tb02796.x)\nTubiana M, Henry-Amar M, Burgers MV, van der Werf-Messing B, Hayat M. Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease. J Clin Oncol 1984; 2: 194-200.\n[https://doi.org/10.1200/JCO.1984.2.3.194](https://doi.org/10.1200/JCO.1984.2.3.194)\nFriedman S, Henry-Amar M, Cosset JM, Carde P, Hayat M, Dupouy N, et al. Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease. J Clin Oncol 1988; 6: 596- 602.\n[https://doi.org/10.1200/JCO.1988.6.4.596](https://doi.org/10.1200/JCO.1988.6.4.596)\nFriedman S, Henry-Amar M, Cosset JM, Carde P, Hayat M, Dupouy N, et al. Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease. Am J Hematol 1991; 37: 253-257.\n[https://doi.org/10.1002/ajh.2830370408](https://doi.org/10.1002/ajh.2830370408)\nHenry-Amar M, Friedman S, Hayat M, Somers R, Meerwaldt JH, Carde P, et al. Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group. Ann Intern Med 1991; 114: 361-365. https:/", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#siteNav", "#pkp_content_footer", "\t\t\t\t\t\thttps://medicinaylaboratorio.com/index.php/myl/index\n\t\t\t\t\t", null, "https://medicinaylaboratorio.com/index.php/myl/issue/current", "https://medicinaylaboratorio.com/index.php/myl/issue/archive", "https://medicinaylaboratorio.com/index.php/myl/educontinua", "https://medicinaylaboratorio.com/index.php/myl/about", "https://medicinaylaboratorio.com/index.php/myl/about", "https://medicinaylaboratorio.com/index.php/myl/politica", "https://medicinaylaboratorio.com/index.php/myl/about/editorialTeam", "https://medicinaylaboratorio.com/index.php/myl/contacto", "https://medicinaylaboratorio.com/index.php/myl/search/search", "#", "https://medicinaylaboratorio.com/index.php", "https://doi.org/10.36384/issn.0123-2576", "https://medicinaylaboratorio.com/index.php/myl/user/register", "https://medicinaylaboratorio.com/index.php/myl/login", "https://medicinaylaboratorio.com/index.php", null, "https://medicinaylaboratorio.com/index.php/myl/index", "https://medicinaylaboratorio.com/index.php/myl/issue/archive", "https://medicinaylaboratorio.com/index.php/myl/issue/view/50", "#resumen", "#author", ".downloads_chart", "#references", "#citations", "https://doi.org/10.5858/2003-127-0440-COLT", "https://doi.org/10.1309/AJCPSB4AL5EHAWTC", "https://doi.org/10.1097/00007611-199803000-00001", "https://doi.org/10.3810/pgm.1998.05.493", "https://doi.org/10.7326/0003-4819-104-4-515", "https://doi.org/10.3109/02813439109026591", "https://doi.org/10.1016/S0272-2712(18)30408-6", "https://doi.org/10.1515/bchm2.1897.23.4-5.368", "https://doi.org/10.1111/j.0954-6820.1921.tb15179.x", "https://doi.org/10.1097/00000441-193301000-00007", "https://doi.org/10.1093/ajcp/68.4.505", "https://doi.org/10.1136/jcp.41.11.1203", "https://doi.org/10.1016/j.colsurfb.2009.08.036", "https://doi.org/10.1016/j.colsurfb.2009.08.037", "https://doi.org/10.1016/0002-9343(86)90349-9", "https://doi.org/10.1016/0049-3848(76)90062-1", "https://doi.org/10.3233/BIR-1977-14104", "https://doi.org/10.1055/s-0038-1666914", "https://doi.org/10.1007/BF01468593", "https://doi.org/10.1093/ajcp/43.2_ts.173", "https://doi.org/10.1093/ajcp/62.4.502", "https://doi.org/10.1097/00000441-193501000-00012", "https://doi.org/10.1136/ard.17.2.234", "https://doi.org/10.1016/S0022-3476(70)80487-5", "https://doi.org/10.1185/03007997809111907", "https://doi.org/10.1088/0967-3334/15/4/011", "https://doi.org/10.1093/ajcp/64.2.254", "https://doi.org/10.1016/S0733-8627(20)30984-6", "https://doi.org/10.1136/jcp.44.11.946", "https://doi.org/10.1093/ajcp/110.3.334", "https://doi.org/10.1309/YHYL-8XTH-5JM2-43EJ", "https://doi.org/10.1136/jcp.42.3.313", "https://doi.org/10.1038/eye.1999.222", "https://doi.org/10.1136/jcp.44.5.429", "https://doi.org/10.1136/bmj.2.5544.85", "https://doi.org/10.1136/bmj.286.6361.266", "https://doi.org/10.1111/j.1471-0528.1953.tb14079.x", "https://doi.org/10.1111/j.0954-6820.1958.tb15548.x", "https://doi.org/10.1016/S0306-5456(01)00267-4", "https://doi.org/10.1136/bmj.3.5559.214", "https://doi.org/10.1172/JCI101987", "https://doi.org/10.1056/NEJM194811252392203", "https://doi.org/10.1001/jama.1949.62910050005008", "https://doi.org/10.1136/jcp.12.3.262", "https://doi.org/10.1016/S0196-0644(05)80790-5", "https://doi.org/10.1136/jech.21.3.133", "https://doi.org/10.1016/S0022-3476(75)80233-2", "https://doi.org/10.1038/bjc.1962.6", "https://doi.org/10.1111/j.1532-5415.1970.tb01334.x", "https://doi.org/10.1093/fampra/19.5.436", "https://doi.org/10.1016/S0007-117X(70)80078-6", "https://doi.org/10.1097/00003086-198207000-00030", "https://doi.org/10.2106/00004623-198769010-00025", "https://doi.org/10.1007/s11999-009-0936-1", "https://doi.org/10.2106/00004623-198769050-00032", "https://doi.org/10.1111/j.0954-6820.1926.tb14045.x", "https://doi.org/10.3109/03009748209098168", "https://doi.org/10.1136/ard.2006.051391", "https://doi.org/10.1186/ar2903", "https://doi.org/10.1002/jor.1100020307", "https://doi.org/10.1212/WNL.7.7.480", "https://doi.org/10.1002/1097-0142(19850401)55:7", "https://doi.org/10.1001/archinte.1975.00330050089015", "https://doi.org/10.3109/03009739409179363", "https://doi.org/10.1345/aph.1L467", "https://doi.org/10.1007/s002780050026", "https://doi.org/10.1016/S0366-0869(55)80090-1", "https://doi.org/10.1136/bmj.3.5559.218", "https://doi.org/10.1177/000992288001901108", "https://doi.org/10.3109/00365549009027093", "https://doi.org/10.1016/S0163-4453(98)93198-X", "https://doi.org/10.1183/09031936.97.10051125", "https://doi.org/10.1097/00006454-200007000-00003", "https://doi.org/10.1097/00006454-199506000-00004", "https://doi.org/10.1111/j.1442-200X.1996.tb03714.x", "https://doi.org/10.1163/156855900300109224", "https://doi.org/10.1007/BF02759832", "https://doi.org/10.1136/adc.61.1.24", "https://doi.org/10.1097/00003081-197603000-00014", "https://doi.org/10.1515/cclm.1991.29.11.749", "https://doi.org/10.1016/0002-9378(93)90271-J", "https://doi.org/10.1016/S0020-7292(97)00236-1", "https://doi.org/10.1007/BF02047214", "https://doi.org/10.1007/BF02049151", "https://doi.org/10.3109/00365519709084584", "https://doi.org/10.1007/s002689910076", "https://doi.org/10.1177/000313480507100414", "https://doi.org/10.4103/1319-3767.48969", "https://doi.org/10.2307/40097967", "https://doi.org/10.1097/00000441-194902000-00014", "https://doi.org/10.1007/BF01644441", "https://doi.org/10.1016/j.jemermed.2003.04.006", "https://doi.org/10.1097/01241398-198403000-00004", "https://doi.org/10.1097/00006454-199704000-00015", "https://doi.org/10.3109/00365548609032370", "https://doi.org/10.1007/BF02113580", "https://doi.org/10.5694/j.1326-5377.1971.tb50309.x", "https://doi.org/10.1136/sti.52.5.309", "https://doi.org/10.1590/S1413-86702008000600005", "https://doi.org/10.4314/njm.v17i4.37425", "https://doi.org/10.4314/njm.v18i2.45067", "https://doi.org/10.1007/BF02247809", "https://doi.org/10.1016/0035-9203(83)90055-X", "https://doi.org/10.3109/00365548909167449", "https://doi.org/10.7326/0003-4819-40-5-1026", "https://doi.org/10.1002/jcla.1860040316", "https://doi.org/10.1002/art.1780310302", "https://doi.org/10.1136/ard.7.4.235", "https://doi.org/10.1136/ard.33.1.53", "https://doi.org/10.1093/rheumatology/14.2.101", "https://doi.org/10.1136/ard.38.4.362", "https://doi.org/10.1136/ard.62.7.681", "https://doi.org/10.1080/17402520500233510", "https://doi.org/10.1136/ard.13.4.336", "https://doi.org/10.1185/03007997509114779", "https://doi.org/10.1136/bmj.1.6124.1396", "https://doi.org/10.1136/ard.38.2.141", "https://doi.org/10.1007/BF00547416", "https://doi.org/10.1136/ard.39.1.18", "https://doi.org/10.1093/rheumatology/25.1.44", "https://doi.org/10.1093/rheumatology/26.2.136", "https://doi.org/10.1136/bmj.1.6055.195", "https://doi.org/10.1136/ard.2006.063834", "https://doi.org/10.3109/00313029109060809", "https://doi.org/10.1016/S0140-6736(57)90300-8", "https://doi.org/10.1016/S0140-6736(57)92105-0", "https://doi.org/10.1136/ard.17.3.319", "https://doi.org/10.1093/ajcp/29.4.331", "https://doi.org/10.1172/JCI100825", "https://doi.org/10.1001/jama.268.15.2069", "https://doi.org/10.1002/art.1780330810", "https://doi.org/10.7326/0003-4819-77-6-845", "https://doi.org/10.7326/0003-4819-88-2-162", "https://doi.org/10.1136/ard.40.5.493", "https://doi.org/10.1097/00007611-198712000-00010", "https://doi.org/10.1001/archopht.1987.01060070101037", "https://doi.org/10.1001/archopht.1988.01060130335006", "https://doi.org/10.1136/ard.48.8.667", "https://doi.org/10.1136/bjo.75.11.656", "https://doi.org/10.1111/j.1365-2141.1994.tb08342.x", "https://doi.org/10.1093/rheumatology/33.6.550", "https://doi.org/10.1016/j.ophtha.2005.02.016", "https://doi.org/10.1016/j.ophtha.2006.05.020", "https://doi.org/10.1016/j.semarthrit.2007.10.014", "https://doi.org/10.7326/0003-4819-103-5-808_2", "https://doi.org/10.1016/0002-9343(86)90645-5", "https://doi.org/10.1016/0002-9343(87)90414-1", "https://doi.org/10.1111/j.1365-2230.1988.tb01971.x", "https://doi.org/10.1111/j.1365-2796.1990.tb00158.x", "https://doi.org/10.1002/art.1780340214", "https://doi.org/10.1002/art.1780341215", "https://doi.org/10.1111/j.1445-5994.1994.tb04430.x", "https://doi.org/10.1097/01.rhu.0000173621.55149.d6", "https://doi.org/10.1016/j.ajem.2008.06.032", "https://doi.org/10.1136/ard.38.5.434", "https://doi.org/10.1136/ard.36.6.560", "https://doi.org/10.1001/archinte.1986.00360230229033", "https://doi.org/10.1093/rheumatology/36.4.508b", "https://doi.org/10.7326/0003-4819-128-10-199805150-00021", "https://doi.org/10.1053/sarh.2000.8366", "https://doi.org/10.1136/ard.50.6.362", "https://doi.org/10.1056/NEJM199901143400207", "https://doi.org/10.5694/j.1326-5377.1969.tb62400.x", "https://doi.org/10.1016/0021-9150(82)90130-7", "https://doi.org/10.1016/S0002-9149(02)02539-0", "https://doi.org/10.1136/bmj.2.5868.681", "https://doi.org/10.1136/bmj.3.5871.109-b", "https://doi.org/10.1016/j.cccn.2003.11.013", "https://doi.org/10.1016/S1052-3057(98)80141-9", "https://doi.org/10.1161/01.STR.26.4.573", "https://doi.org/10.1111/j.1445-5994.2008.01811.x", "https://doi.org/10.5858/2002-126-0772-PVOTES", "https://doi.org/10.1016/0895-4356(94)00156-K", "https://doi.org/10.1053/euhj.1999.1699", "https://doi.org/10.1053/euhj.2000.2148", "https://doi.org/10.1053/euhj.2000.2236", "https://doi.org/10.1093/aje/kwg222", "https://doi.org/10.1016/S0195-668X(02)00741-8", "https://doi.org/10.1016/j.ijcard.2004.05.008", "https://doi.org/10.1001/archinte.1954.00240260067006", "https://doi.org/10.1016/0002-8703(54)90190-8", "https://doi.org/10.1111/j.0954-6820.1956.tb14394.x", "https://doi.org/10.1016/0002-9343(56)90127-9", "https://doi.org/10.1111/j.0954-6820.1957.tb00093.x", "https://doi.org/10.1001/jama.1957.02980320006003", "https://doi.org/10.1111/j.1365-2796.2005.01478.x", "https://doi.org/10.1097/00006454-200107000-00011", "https://doi.org/10.1093/tropej/fmh087", "https://doi.org/10.1097/00000441-195306000-00002", "https://doi.org/10.1111/j.0954-6820.1961.tb17096.x", "https://doi.org/10.1056/NEJM199102073240601", "https://doi.org/10.1016/j.jacc.2005.02.066", "https://doi.org/10.1136/ard.2006.053710", "https://doi.org/10.1016/S0161-6420(80)35110-5", "https://doi.org/10.1093/rheumatology/ken437", "https://doi.org/10.1016/j.ophtha.2009.07.043", "https://doi.org/10.1373/clinchem.2008.119214", "https://doi.org/10.5694/j.1326-5377.1979.tb119387.x", "https://doi.org/10.1016/S0007-0971(61)80017-X", "https://doi.org/10.1126/science.1246598", "https://doi.org/10.2190/8D35-C4UE-BWD5-KBX2", "https://doi.org/10.1111/j.13497006.1990.tb03333.x", "https://doi.org/10.1002/1097-0142(19920915)70:6", "https://doi.org/10.3109/02841869709001338", "https://doi.org/10.1002/mrm.1910050604", "https://doi.org/10.1159/000474890", "https://doi.org/10.1046/j.1365-2796.1996.30195852000.x", "https://doi.org/10.1038/sj.bjc.6603387", "https://doi.org/10.1002/cncr.21617", "https://doi.org/10.1002/cncr.22896", "https://doi.org/10.1177/117727190600100017", "https://doi.org/10.1159/000241673", "https://doi.org/10.1002/1097-0142(197306)31:6", "https://doi.org/10.1016/0360-3016(77)90080-3", "https://doi.org/10.1111/j.1365-2362.1977.tb01607.x", "https://doi.org/10.1002/1097-0142(197810)42:4", "https://doi.org/10.1111/j.1600-0609.1979.tb02796.x", "https://doi.org/10.1200/JCO.1984.2.3.194", "https://doi.org/10.1200/JCO.1988.6.4.596", "https://doi.org/10.1002/ajh.2830370408", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/acm-sig-proceedings?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/acs-nano?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/apa?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/associacao-brasileira-de-normas-tecnicas?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/chicago-author-date?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/harvard-cite-them-right?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/ieee?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/modern-language-association?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/turabian-fullnote-bibliography?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/get/vancouver?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/download/ris?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20citationstylelanguage/download/bibtex?submissionId=378&publicationId=279", "https://medicinaylaboratorio.com/index.php/myl/%20issue/view/50", "https://medicinaylaboratorio.com/index.php/myl/article/view/378/354", "https://medicinaylaboratorio.com/index.php/myl/%20issue/view/50", null, null, null, null, null, null, "https://medicinaylaboratorio.com/index.php/myl/user/setLocale/en_US?source=%2Findex.php%2Fmyl%2Farticle%2Fview%2F378", "https://medicinaylaboratorio.com/index.php/myl/user/setLocale/es_ES?source=%2Findex.php%2Fmyl%2Farticle%2Fview%2F378", "https://medicinaylaboratorio.com/index.php/myl/about/submissions", "https://medicinaylaboratorio.com/index.php/myl/proceso", "https://medicinaylaboratorio.com/index.php/myl/contacto", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/18", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/3", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/28", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/20", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/21", "https://medicinaylaboratorio.com/index.php/myl/libraryFiles/downloadPublic/22", "https://dialnet.unirioja.es/servlet/revista?codigo=27870", "https://www.latindex.org/latindex/ficha/10217", "https://periodica.dgb.unam.mx/F/XQ5EENY222FT41V5ASLD2QI511TJTC1HN4FBXBQHKF9VDT5F6D-11530?func=find-b&request=Medicina+%26+Laboratorio&find_code=WRE&adjacent=N&local_base=PER01&x=57&y=15&filter_code_1=WLN&filter_request_1=&filter_code_2=WYR&filter_request_2=&filter_code_3=WYR&filter_request_3=", "https://lilacs.bvsalud.org/es/revistas-lilacs/revistas-indexadas-en-lilacs/", "https://www.redib.org/Record/oai_revista6619-medicina-y-laboratorio", "https://www.medigraphic.com/cgi-bin/new/publicaciones.cgi?IDREVISTA=215", "https://biblat.unam.mx/es/buscar/revista/medicina&laboratorio", "https://doaj.org/toc/2500-7106?source=%7B%22query%22%3A%7B%22bool%22%3A%7B%22must%22%3A%5B%7B%22terms%22%3A%7B%22index.issn.exact%22%3A%5B%220123-2576%22%2C%222500-7106%22%5D%7D%7D%5D%7D%7D%2C%22size%22%3A100%2C%22sort%22%3A%5B%7B%22created_date%22%3A%7B%22order%22%3A%22desc%22%7D%7D%5D%2C%22_source%22%3A%7B%7D%2C%22track_total_hits%22%3Atrue%7D", "https://scholar.google.com/citations?hl=es&user=vB9lGYIAAAAJ", "/index.php/myl/estadisticas", "/index.php/myl/estadisticas", null, "https://doi.org/10.36384/issn.0123-2576", "https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es", "https://medicinaylaboratoriocom.biteca.online", "https://www.edimeco.com", "https://medicinaylaboratorio.com/index.php/myl/about/aboutThisPublishingSystem"]}